Sonal S. Das

Sonal S. Das has extensive work experience in the biotechnology and research fields. Sonal S. is currently serving as the Senior Director of Commercial New Product Planning at Argenx, a position they have held since August 2022. Prior to that, Sonal worked at Biogen, where they held various roles including Director of External Innovation, Associate Director of External Innovation and New Indications, and Senior Manager of Business Development & External Innovation from 2016 to 2022.

Before joining Biogen, Sonal was a Research Manager at the MRC-Protein Phosphorylation and Ubiquitylation Unit at The University of Dundee from 2014 to 2015. Sonal S. also worked at The Michael J. Fox Foundation for Parkinson's Research, where they held positions as Senior Associate Director and Associate Director of Research Programs from 2009 to 2013.

Sonal's earlier work experience includes a three-year tenure as a Senior Postdoctoral Fellow at the University of Washington's Department of Physiology and Biophysics, where they conducted basic research on molecular mechanisms governing Aquaporin-4 localization in the central nervous system. Sonal S. developed experimental plans and utilized molecular, cellular, and biochemical techniques throughout their research.

Sonal S. Das completed a Global Executive MBA '21 degree at INSEAD from 2019 to 2021. Additionally, Sonal holds a BA degree in Biological Sciences (Focus: Neurobiology & Behavior) from Cornell University. There is no information provided regarding the completion dates and degree status for the PhD in Neuroscience from Oregon Health & Science University.